Candidate genes and psychiatric genetics: Tomorrow never knows

Psychiatric Annals

Volumn 27, Issue 4, 1997, Pages 262-267

  Gelernter, Joel ^a,b,d   Crowe, Raymond R ^c  

^a VETERANS AFFAIRS MEDICAL CENTER   (United States)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF IOWA   (United States)

^d VA CONNECTICUT HEALTHCARE SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 6244247470     PISSN: 00485713     EISSN: None     Source Type: Journal    
DOI: 10.3928/0048-5713-19970401-08     Document Type: Article

References (36)

1. Tien AY. Psychiatric epidemiology and information technology. Psychiatric Annals. 1997; 27:268-272.
2. Cubells JF. An introductory overview of mutational analysis in psychiatric genetics. Psychiatric Annals. 1997; 27:273-278.
3. Rao PA. Review of gene mapping and molecular genetic studies of schizophrenia. Psychiatric Annals. 1997; 27:279-284.
4. Kelsoe JR. The genetics of bipolar disorder. Psychiatric Annals. 1997; 27:285-292.
5. Leckman JF. What genes confer vulnerability to Gilles de la Tourette's syndrome? Psychiatric Annals. 1997; 27:293-296.
6. Brunner HG, Nelen M, Breakefield XO, Ropers HH, van Oost BA. Abnormal behavior associated with a point mutation in the structural gene for monoamine oxidase A. Science. 1993; 262:578-580.
7. Brunner HG, Nelen M, van Zandvoort P, et al. X-linked borderline mental retardation with prominent behavior: phenotype, genetic localization, and evidence for disturbed monoamine metabolism. Am J Hum Genet. 1993; 52:1032-1039.
8. Gelernter J, Goldman D, Risch N. The A1 allele at the D2 dopamine receptor gene and alcoholism: a reappraisal. JAMA. 1993; 269:1673-1677.
9. Uhl G, Blum K, Noble E, Smith S. Substance abuse vulnerability and D2 receptor genes. Trends Neurosci. 1993; 16:83-88.
10. Gelernter J. Genetics of bipolar disorder: time for another reinvention? Am J Hum Genet. 1995; 56:1262-1266.
11. Schmidt SM, Zoega T, Crowe RR. Excluding linkage between panic disorder and the gamma-aminobutyric acid beta 1 receptor locus in five Icelandic pedigrees. Acta Psychiatr Scand. 1993; 88:225-228.
12. Comings DE, Comings BG, Muhleman D, et al. The dopamine D2 receptor locus as a modifying gene in neuropsychiatric disorders. JAMA. 1991; 266:1793-1800.
13. Van Tol HHM, Caren MW, Guan H-C, et al. Multiple dopamine D4 receptor variants in the human population. Nature. 1992; 358:149-152.
14. Ebstein RP, Novick O, Umansky R, et al. Dopamine D4 (D4DR) exon III polymorphism associated with the human personality trait of novelty seeking. Nat Genet. 1996; 12:78-80.
15. Benjamin J, Li L, Patterson C, Greenberg BD, Murphy DL, Hamer DH. Population and familial association between the D4 dopamine receptor gene and measures of novelty seeking. Nat Genet. 1996; 12:81-84.
16. Grice DE, Leckman JF, Pauls DL, et al. Linkage disequilibrium between an allele at the dopamine D4 receptor locus with Tourette's syndrome, by the transmission-disequilibrium test. Am J Hum Genet. 1996; 59:644-652.
17. Vandenbergh DJ, Persico AM, Hawkins AL, et al. Human dopamine transporter gene maps to chromosome 5p15.3 and displays a VNTR. Genomics. 1992; 14:1104-1106.
18. Krontiris TG. Minisatellites and human disease. Science. 1995; 269:1682-1683.
19. Gelernter J, Kranzler HR, Satel SL, Rao PA. Genetic association between dopamine transporter protein alleles and cocaine-induced paranoia. Neuropsychopharmacology. 1994; 11:195-200.
20. Cook EH Jr, Stein MS, Krasowski MD, et al. Association of attention-deficit disorder and the dopamine transporter gene. Am J Hum Genet. 1995; 56:993-996.
21. Van Kammen DP, Gelernter J. Biochemical instability in schizophrenia, II: the serotonin and gamma-aminobutyric acid systems. In: Meltzer, et al, eds. Psychopharmacology, The Third Generation of Progress, New York, NY: Raven Press; 1987.
22. Williams J, Spurlock G, McGuffin P, et al. Association between schizophrenia and the T102C polymorphism of the 5-hydroxytryptamine type 2a-receptor gene. Lancet. 1996; 347:1294-1296.
23. Inayama Y, Yoneda H, Sakai T, et al. Positive association between a DNA sequence variant in the serotonin 2A receptor gene and schizophrenia. Am J Med Genet. 1996; 67:103-105.
24. Erdmann J, Shimron-Abarbanell D, Rietschel M. Systematic screening for mutations in the human serotonin-2A (5-HT2A) receptor gene: identification of two naturally occurring receptor variants and association analysis in schizophrenia. Hum Genet. 1996; 97:614-619.
25. Ogilvie AD, Battersby S, Bubb VJ, et al. Polymorphism in serotonin transporter gene associated with susceptibility to major depression. Lancet. 1996; 347:731-733.
26. Heils A, Teufel A, Petri S, et al. Allelic variation of human serotonin transporter gene expression. J Neurochem. 1996; 66:2621-2624.
27. Nielsen DA, Goldman D, Virkkunen M, Tokola R, Rawlings R, Linnoila M. Suicidality and 5-hydroxyindolacetic acid concentration associated with a tryptophan hydroxylase polymorphism. Arch Gen Psychiatry. 1994; 51:34-38.
28. Corder EH, Saunders AM, Strittmatter WJ, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families. Science. 1993; 261:921-923.
29. Corder EH, Saunders AM, Risch NJ, et al. Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer's disease. Nat Genet. 1994; 7:180-184.
30. Goate A, Chartier-Harlin MC, Mullan M, et al. Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature. 1991; 349:704-706.
31. Hendriks L, van Duijn CM, Cras P, et al. Presenile dementia and cerebral hemorrhage linked to a mutation at codon 692 of the β-amyloid precursor protein gene. Nat Genet. 1992; 1:218-221.
32. Crocq M-A, Mant R, Asherson P, et al. Association between schizophrenia and homozygosity at the dopamine D3 receptor gene. J Med Genet. 1992; 29:858-860.
33. Thomasson HR, Edenberg HJ, Crabb DW, et al. Alcohol and aldehyde dehydrogenase genotypes and alcoholism in Chinese men. Am J Hum Genet. 1991; 48:677-681.
34. Thome J, Kornhuber J, Baumer A, Rösler M, Beckmann H, Riederer P. Association between a null mutation in the human ciliary neurotrophio factor (CNTF) gene and increased incidence of psychiatric diseases? Neurosci Lett. 1996b; 203:109-110.
35. Nanko S, Hattori M, Kuwata S, et al. Neurotrophin-3 gene polymorphism associated with schizophrenia. Acta Psychiatr Scand. 1994; 89:390-392.
36. Saunders AM, Strittmatter WJ, Schmechel D, et al. Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease. Neurology. 1993; 43:1467-1472.